Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart-Assist Devices | 11 | 2024 | 1292 | 1.540 |
Why?
|
Heart Failure | 15 | 2024 | 11859 | 0.900 |
Why?
|
Shock, Cardiogenic | 3 | 2023 | 711 | 0.750 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2022 | 252 | 0.660 |
Why?
|
Correspondence as Topic | 1 | 2018 | 34 | 0.590 |
Why?
|
Auscultation | 1 | 2017 | 38 | 0.560 |
Why?
|
Stethoscopes | 1 | 2017 | 30 | 0.550 |
Why?
|
Pulsatile Flow | 1 | 2017 | 320 | 0.540 |
Why?
|
Nephrolithiasis | 1 | 2018 | 117 | 0.530 |
Why?
|
Aortic Diseases | 1 | 2022 | 742 | 0.520 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2023 | 1482 | 0.470 |
Why?
|
Heart Rate | 3 | 2023 | 4218 | 0.430 |
Why?
|
Respiratory Sounds | 1 | 2017 | 702 | 0.410 |
Why?
|
Hypercholesterolemia | 3 | 2024 | 1142 | 0.410 |
Why?
|
Speech | 1 | 2017 | 558 | 0.390 |
Why?
|
Blood Pressure | 4 | 2023 | 8537 | 0.280 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6549 | 0.250 |
Why?
|
Ventricular Function, Left | 2 | 2021 | 3941 | 0.240 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2023 | 3253 | 0.220 |
Why?
|
Hypertension | 3 | 2018 | 8610 | 0.210 |
Why?
|
Primary Graft Dysfunction | 1 | 2023 | 112 | 0.200 |
Why?
|
Seed Storage Proteins | 1 | 2022 | 15 | 0.200 |
Why?
|
Germination | 1 | 2022 | 17 | 0.200 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11515 | 0.200 |
Why?
|
Bed Occupancy | 1 | 2022 | 38 | 0.200 |
Why?
|
Hyperemia | 1 | 2023 | 225 | 0.200 |
Why?
|
Heart Failure, Systolic | 1 | 2023 | 135 | 0.200 |
Why?
|
Pandemics | 1 | 2022 | 8751 | 0.190 |
Why?
|
Seeds | 1 | 2022 | 124 | 0.190 |
Why?
|
Hemodynamics | 2 | 2023 | 4202 | 0.170 |
Why?
|
Hospital Mortality | 3 | 2022 | 5371 | 0.160 |
Why?
|
History, 17th Century | 1 | 2018 | 109 | 0.150 |
Why?
|
Atherosclerosis | 2 | 2024 | 3431 | 0.150 |
Why?
|
von Willebrand Factor | 1 | 2021 | 679 | 0.140 |
Why?
|
Retrospective Studies | 12 | 2024 | 81835 | 0.140 |
Why?
|
Humans | 34 | 2024 | 768369 | 0.140 |
Why?
|
Dyssomnias | 1 | 2016 | 28 | 0.130 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15638 | 0.130 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2396 | 0.130 |
Why?
|
Aorta, Thoracic | 1 | 2022 | 1107 | 0.130 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2021 | 1890 | 0.120 |
Why?
|
Blood Pressure Determination | 1 | 2018 | 646 | 0.120 |
Why?
|
History, 19th Century | 1 | 2017 | 716 | 0.120 |
Why?
|
Risk Factors | 11 | 2024 | 74915 | 0.120 |
Why?
|
Renal Replacement Therapy | 1 | 2016 | 283 | 0.120 |
Why?
|
Hemolysis | 1 | 2016 | 419 | 0.120 |
Why?
|
Proteinuria | 1 | 2016 | 613 | 0.110 |
Why?
|
Thrombosis | 2 | 2018 | 2954 | 0.110 |
Why?
|
Endothelium, Vascular | 2 | 2016 | 4426 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2020 | 874 | 0.110 |
Why?
|
Middle Aged | 13 | 2024 | 223406 | 0.100 |
Why?
|
Mitral Valve Insufficiency | 1 | 2021 | 1414 | 0.100 |
Why?
|
Phenotype | 4 | 2024 | 16712 | 0.100 |
Why?
|
Endocytosis | 1 | 2016 | 960 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 3 | 2024 | 20763 | 0.090 |
Why?
|
Angiopoietin-2 | 2 | 2023 | 173 | 0.090 |
Why?
|
Endothelial Cells | 3 | 2023 | 3586 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 2016 | 809 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2145 | 0.090 |
Why?
|
Hemoglobins | 1 | 2016 | 1532 | 0.090 |
Why?
|
Heart Ventricles | 1 | 2022 | 3839 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2561 | 0.090 |
Why?
|
Heart Transplantation | 1 | 2023 | 3291 | 0.080 |
Why?
|
Peptides | 1 | 2022 | 4368 | 0.080 |
Why?
|
Male | 15 | 2024 | 364761 | 0.080 |
Why?
|
Patient Readmission | 1 | 2023 | 3308 | 0.080 |
Why?
|
Tobacco Smoke Pollution | 1 | 2015 | 828 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5793 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3906 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2022 | 3804 | 0.080 |
Why?
|
Arteries | 1 | 2013 | 1126 | 0.080 |
Why?
|
Warfarin | 1 | 2016 | 1493 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2226 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2018 | 2780 | 0.070 |
Why?
|
Pericardium | 2 | 2021 | 679 | 0.070 |
Why?
|
New York | 2 | 2020 | 881 | 0.070 |
Why?
|
Female | 14 | 2024 | 396926 | 0.070 |
Why?
|
Stroke | 2 | 2018 | 9790 | 0.060 |
Why?
|
Prosthesis Design | 2 | 2023 | 2126 | 0.060 |
Why?
|
Risk Assessment | 2 | 2022 | 24310 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 5162 | 0.050 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2023 | 223 | 0.050 |
Why?
|
Chromatography | 1 | 2022 | 189 | 0.050 |
Why?
|
Adult | 6 | 2023 | 223528 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5887 | 0.050 |
Why?
|
Electrophoresis | 1 | 2022 | 226 | 0.050 |
Why?
|
Endothelin-1 | 1 | 2023 | 302 | 0.050 |
Why?
|
Aged | 7 | 2024 | 171514 | 0.050 |
Why?
|
Middle Cerebral Artery | 1 | 2023 | 275 | 0.050 |
Why?
|
Weibel-Palade Bodies | 1 | 2021 | 19 | 0.050 |
Why?
|
Inflammation | 2 | 2023 | 10863 | 0.050 |
Why?
|
Anticoagulants | 1 | 2016 | 4835 | 0.040 |
Why?
|
Adipose Tissue | 2 | 2021 | 3335 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 41782 | 0.040 |
Why?
|
Oxidative Stress | 2 | 2023 | 3145 | 0.040 |
Why?
|
Stroke Volume | 2 | 2023 | 5620 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 9099 | 0.040 |
Why?
|
Microcirculation | 1 | 2023 | 1283 | 0.040 |
Why?
|
Urofollitropin | 1 | 2016 | 2 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1820 | 0.030 |
Why?
|
Complement Membrane Attack Complex | 1 | 2016 | 105 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 921 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2016 | 413 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2016 | 382 | 0.030 |
Why?
|
Cotinine | 1 | 2015 | 207 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 564 | 0.030 |
Why?
|
Urinalysis | 1 | 2016 | 369 | 0.030 |
Why?
|
Equipment Failure | 1 | 2016 | 585 | 0.030 |
Why?
|
Brachial Artery | 1 | 2015 | 374 | 0.030 |
Why?
|
Survival Rate | 2 | 2018 | 12875 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2015 | 706 | 0.020 |
Why?
|
Biological Transport | 1 | 2016 | 2090 | 0.020 |
Why?
|
Vasodilation | 1 | 2015 | 968 | 0.020 |
Why?
|
Tyrosine | 1 | 2015 | 1428 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21552 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2016 | 1163 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2021 | 3123 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 30031 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3623 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6278 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3471 | 0.020 |
Why?
|
Sleep Apnea Syndromes | 1 | 2016 | 981 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 22286 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8372 | 0.020 |
Why?
|
Models, Statistical | 1 | 2022 | 5103 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 17492 | 0.020 |
Why?
|
NF-kappa B | 1 | 2015 | 2491 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2910 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2016 | 4247 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6537 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 19035 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2013 | 1898 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15459 | 0.010 |
Why?
|
Hemorrhage | 1 | 2016 | 3456 | 0.010 |
Why?
|
Hospitalization | 1 | 2024 | 10845 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 13045 | 0.010 |
Why?
|
Electrocardiography | 1 | 2013 | 6410 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2016 | 7895 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40271 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20232 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15879 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59679 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65408 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26348 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 60038 | 0.000 |
Why?
|
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_